[Short communication: hepatitis B, hepatitis C and human immunodeficiency virus seropositivities in women admitted to Sanliurfa Gynecology and Obstetrics Hospital].
The aim of this retrospective study was to determine the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and immune deficiency virus (HIV) in women who were admitted to Sanliurfa Gynecology and Obstetrics Hospital clinics and to compare the results with the previous seropositivity rates reported from different regions of Turkey. The serum samples were screened for HBsAg, anti-HCV and anti-HIV markers by a commercial chemiluminescence method (UniCel Dxl 800, Beckman Coulter, USA), during a six months period (January 1st to June 30th, 2006). As a result the seropositivity rates of HBsAg, anti-HCV and anti-HIV were found as 5.1% (119/2335), 0.9% (18/2066) and 0.1% (3/2548), respectively. While anti-HCV seropositive results were approved by confirmation tests, three of anti-HIV positive results were not confirmed and accepted as false positivities. HBsAg, anti-HCV and anti-HIV seropositivities detected in our study were similar to the rates previously reported in other studies in Turkey. However, HBsAg positivity was found slightly higher than the rates that were reported from western parts of our country. This result may be related to the lower socioeconomical status of Sanliurfa (which is located in Southeast Anatolia), and indicates that HBV should be considered as a serious public health problem in East and Southeast parts of Turkey.